No Data
Even After Rising 3.2% This Past Week, NovoCure (NASDAQ:NVCR) Shareholders Are Still Down 86% Over the Past Three Years
Why NovoCure Stock Dived by 13% This Week
Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $40
Wells Fargo analyst Larry Biegelsen maintains $Novocure(NVCR.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 64.8% and a
Novocure Names Ashley Cordova as CEO
Express News | Novocure Ltd - Ashley Cordova to Succeed Asaf Danziger as Novocure CEO
Express News | Novocure Ltd - Asaf Danziger to Retire as Novocure CEO at Year-End